One of the most important aspects of Congress is developing, making, and monitoring laws. New legislation is passed almost every week. Please contact our office to share your thoughts on current legislation that may affect you, your family, and your community.
Learn more about legislation sponsored and cosponsored by Congressman Arrington, as well as recent votes made by the Congressman.
Providing for consideration of the bill (H.R. 4346) making appropriations for Legislative Branch for the fiscal year ending September 30, 2022, and for other purposes; providing for consideration of the bill (H.R. 4373) making appropriations for the Department of State, foreign operations, and related programs for the fiscal year ending September 30, 2022, and for other purposes; and providing for consideration of the bill (H.R. 4505) making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2022, and for other purposes.
Providing for consideration of the bill (H.R. 4346) making appropriations for Legislative Branch for the fiscal year ending September 30, 2022, and for other purposes; providing for consideration of the bill (H.R. 4373) making appropriations for the Department of State, foreign operations, and related programs for the fiscal year ending September 30, 2022, and for other purposes; and providing for consideration of the bill (H.R. 4505) making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2022, and for other purposes.
Providing for consideration of the bill (H.R. 4346) making appropriations for Legislative Branch for the fiscal year ending September 30, 2022, and for other purposes; providing for consideration of the bill (H.R. 4373) making appropriations for the Department of State, foreign operations, and related programs for the fiscal year ending September 30, 2022, and for other purposes; and providing for consideration of the bill (H.R. 4505) making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2022, and for other purposes.
Amendment sought to allow United States researchers to study and examine the potential impacts of several schedule I drugs, such as MDMA, psilocybin, and or ibogaine, that have been shown to be effective in treating critical diseases.